ProRx recalls 27mg/3mL Tirzepatide injection vials due to lack of sterility assurance. This could lead to infections if used improperly. Affected vials have NDC 84139-209-03 and lot PRORX08062025-3.
Lack of Assurance of Sterility
ProRx is recalling Tirzepatide injections that may not be sterile, which could cause infections. This recall affects people using the medication as prescribed.
The vials lack assurance of sterility, meaning they might be contaminated. If injected, this could lead to infections or other health issues. The risk is not clearly defined in the recall notice.
People with prescriptions for Tirzepatide injections from ProRx. Those using the medication without proper sterility checks are at higher risk.
Check for the NDC code 84139-209-03 and lot number PRORX08062025-3 on the vial label. The product is a 27 mg/3 mL injection vial for subcutaneous use.
Look for the NDC code 84139-209-03 and lot number PRORX08062025-3 on the vial.
The recall states there is a lack of sterility assurance, so it is not safe to use without checking the recall.
Check for the NDC code 84139-209-03 and lot number PRORX08062025-3 on the vial label.
The recall does not specify a remedy, so contact ProRx directly for guidance.
We’ve drafted a message you can send ProRx to request your refund or repair — edit it as you like.
Subject: Recall D-0120-2026 — ProRx ProRx Hello, I own a ProRx that is covered by recall D-0120-2026 from ProRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
